1,812 Shares in Encompass Health Corporation $EHC Purchased by Insigneo Advisory Services LLC

Insigneo Advisory Services LLC purchased a new stake in Encompass Health Corporation (NYSE:EHC) in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 1,812 shares of the company’s stock, valued at approximately $222,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. WPG Advisers LLC bought a new stake in Encompass Health during the first quarter worth approximately $27,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in shares of Encompass Health by 749.0% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company’s stock valued at $42,000 after acquiring an additional 367 shares during the last quarter. Parkside Financial Bank & Trust boosted its stake in shares of Encompass Health by 179.5% during the 2nd quarter. Parkside Financial Bank & Trust now owns 478 shares of the company’s stock worth $59,000 after acquiring an additional 307 shares in the last quarter. Park Place Capital Corp acquired a new position in shares of Encompass Health in the 2nd quarter worth $72,000. Finally, Caitong International Asset Management Co. Ltd raised its position in shares of Encompass Health by 19.0% during the first quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock worth $73,000 after purchasing an additional 115 shares during the period. 97.25% of the stock is currently owned by institutional investors.

Encompass Health Price Performance

NYSE EHC opened at $116.36 on Thursday. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06. The firm has a market capitalization of $11.71 billion, a price-to-earnings ratio of 22.00, a price-to-earnings-growth ratio of 2.20 and a beta of 0.91. The company has a 50 day simple moving average of $120.80 and a 200-day simple moving average of $119.53. Encompass Health Corporation has a 52-week low of $87.85 and a 52-week high of $127.99.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Wednesday, March 16th. The company reported $0.93 EPS for the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 18.19%. The firm had revenue of $136.30 million for the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Equities research analysts predict that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be issued a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Friday, January 2nd. Encompass Health’s dividend payout ratio (DPR) is currently 14.37%.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on EHC shares. Barclays lifted their price target on Encompass Health from $141.00 to $150.00 and gave the stock an “overweight” rating in a research note on Thursday, October 30th. Zacks Research cut shares of Encompass Health from a “strong-buy” rating to a “hold” rating in a report on Wednesday, November 19th. Raymond James Financial upgraded shares of Encompass Health to a “strong-buy” rating in a report on Friday, October 31st. Bank of America raised their price objective on shares of Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a research note on Wednesday, September 10th. Finally, KeyCorp lifted their price objective on shares of Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a research report on Tuesday, September 16th. Two research analysts have rated the stock with a Strong Buy rating, eight have issued a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, Encompass Health has a consensus rating of “Buy” and an average target price of $142.86.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.